摘要
目的 :为观察尿激酶在溶栓治疗急性心肌梗塞中的疗效和不良反应并寻找一种更合适的溶栓方法。方法 :我们对 50例 (AMI)病人进行了第四方案的溶栓治疗 ,所有溶栓病例均符合入选和不入选标准。一旦病例被选择 ,立即给予尿激酶 2 0 0万 u,(10 0万 u静脉推注 ,10 0万 u快速静脉点滴 )。溶栓后观察疗效和副反应。结果 :在已进行的 50例溶栓病例中 ,溶栓疗法的总有效率达 95% ,梗塞血管再通率为 86 % ,不良反应发作率低 ,程度轻。结论 :我们认为第四方案 ,是一种安全。
Objective:[WT5BZ]To observe the therapeutic action and untoward reaction of UK(urokinasum)in the dissolution of thrombi on the AMI(Acute myocardial infarction).And to find a better therapy.[WT5HZ]Methods:[WT5BZ]50 AMI cases suits for the selected were chosen to accept the dissolution of thrombi therapy.Once was chosen,The case was given UK 200×10 4u as soon as possible(100×10 4u intravenous injection,100×10 4u intravenous transfusion).Then to observe the therapeutic effect and untoward reaction.[WT5HZ]Results:[WT5BZ]In the 50 cases,curative radio reached to 95 percent and the reactivate ration of infarct vessls reached to 86 percent.[WT5HZ]Conclusion:[WT5BZ]To the AMI,this therpay is a dissolution of thrombi with secure top effect. [WT5HZ]
出处
《河北医学》
CAS
2000年第6期483-485,共3页
Hebei Medicine